ACR seeks help, offers resources ahead of ICD-10 transition

The American College of Radiology (ACR) is asking radiology and radiation oncology practices to be on the lookout for potential errors in the ICD-9 to ICD-10 translation.

The organization is urging providers to alert them and their local Medicare contractor if a previously payable ICD-9 diagnosis code has been omitted from the list of approved and medically necessary ICD-10 diagnosis codes.

Some of the local and national coverage determination (LCDs and NCDs) policies for procedures commonly performed and billed could have slipped through the cracks in the conversion to the vastly more detailed and expanded ICD-10 dataset. Coding specificity required by NCDs and LCDs does not change and all coverage policies that currently require a specific diagnosis under ICD-9 should accurately reflect the equivalent ICD-10 code(s).

The ACR will communicate with the Carrier Advisory Committees in an effort to address any ICD-10 conversion issues and/or omitted diagnosis codes, according to guidance from the organization.

Those policies that have been converted to ICD-10 codes are identified by a “FUTURE” status and are listed with an “October 1, 2015 effective date.”

Guidance from the ACR includes numerous resources for the transition including a downloadable Medicare coverage database that contains Access files that can be used to assist in analyzing all policies including converted ICD-10 LCDs.

ACR also identified trends in the converted LCD files including fewer ICD-10 LCDs, an increased number of diagnosis codes, a small percentage of inaccuracies in ICD-9 to ICD-10 crosswalks, a higher volume of ICD-10 codes tied to more complex coding and not yet posted LCDS which could indicate plans to retire existing policies.

Access the complete guidance.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.